论文部分内容阅读
人白介素-2(IL-2)临床疗效与使用方法密切有关,采用肝动脉插管注入IL-2、化疗药,并以单独注入化疗药物作为对照,同时进行碘油栓塞,治疗原发性肝癌,结果表明:加入IL-2后治疗的有效率明显增加,同时还能改善病人的生活质量,为治疗原发性肝癌提供了一条新的治疗途径。
The clinical efficacy of human interleukin-2 (IL-2) is closely related to its use method. Hepatic artery cannula is used to infuse IL-2 and chemotherapeutic drugs, and chemotherapeutic drugs are injected alone as a control. Simultaneous lipiodol embolization is used to treat primary liver cancer. The results showed that the effective rate of treatment after the addition of IL-2 was significantly increased, and at the same time, the patient’s quality of life was improved, which provided a new therapeutic approach for the treatment of primary liver cancer.